NICE Recommends Two Diagnostics to Detect Endometriosis in England

The National Institute for Health and Care Excellence (NICE) has recommended Endosure and Endotest, two diagnostic tests for endometriosis, for routine use in England. The decision means that women in England will now have access to new, taxpayer-funded tests for the condition.

The recommendation applies to regular use within the National Health Service (NHS). Specific details on the tests’ performance, cost, or implementation timeline were not included in the announcement.

Context for the life sciences

Endometriosis affects an estimated one in ten women of reproductive age, yet diagnosis often takes years due to reliance on invasive surgery or symptom-based assessments. Non-invasive diagnostic tools like Endosure and Endotest represent a shift in how the condition can be identified earlier and more broadly. For biotech and medtech developers, the NICE recommendation signals a growing regulatory and reimbursement pathway for diagnostics targeting women’s health conditions that have historically received less research investment and slower clinical adoption.

Source: original report